FDA appears to have added more leeway for firms making "wellness" products to avoid active regulation in a newly finalized guidance document, according to industry experts.
FDA's guidance document on "General Wellness: Policy for Low-Risk Devices" was finalized from a January 2015 draft version...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?